Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
MK-3475A by Merck for Metastatic Melanoma: Likelihood of Approval
MK-3475A is under clinical development by Merck and currently in Phase II for Metastatic Melanoma. According to GlobalData, Phase II...
MK-3475A by Merck for Metastatic Renal Cell Carcinoma: Likelihood of Approval
MK-3475A is under clinical development by Merck and currently in Phase II for Metastatic Renal Cell Carcinoma. According to GlobalData,...
MK-3475A by Merck for Solid Tumor: Likelihood of Approval
MK-3475A is under clinical development by Merck and currently in Phase I for Solid Tumor. According to GlobalData, Phase I...
MK-3475A by Merck for Non-Small Cell Lung Cancer: Likelihood of Approval
MK-3475A is under clinical development by Merck and currently in Phase III for Non-Small Cell Lung Cancer. According to GlobalData,...